Sanofi wants to cut 400 research and development jobs

Sanofi wants to cut 400 research and development jobs

A decision revealed by France Inter that the CGT considers “unacceptable”, especially since the company is behind in the race for the vaccine against Covid-19.

The head office of Sanofi in Gentilly in the Val-de-Marne.  (LAETITIA SAAVEDRA / RADIOFRANCE)

The pharmaceutical group Sanofi wants to cut 400 jobs in the research and development branch of its pharmaceutical sector, France Inter said Monday, January 18, from union sources. These positions are included in the 1,000 job cuts that were announced last summer, according to the unions. Management refuses to confirm this figure.

“The very words of the Director General were categorical: 400 job cuts in pharmaceutical R&D in France, this is not acceptable”, denounces Thierry Bodin, CGT-Sanofi delegate. These job cuts worry him all the more since the company is behind in the global race for the vaccine against Covid-19. “The losses of expertise that we have had in recent years, we pay them cash”, believes Thierry Bodin.

A call to strike launched for Tuesday

The CGT launched a call to disengage Tuesday, January 19 to protest against this plan of cuts but also to demand a rise in wages. “In March-April the management of Sanofi praised the investment of employees particularly around the vaccine and then in December when there were negotiations on wages, it was zero. After a while it’s not possible ”. Management replied that an exceptional bonus of 1,500 euros was distributed to 15,000 employees mobilized during the crisis and that it did not resort to partial unemployment. The unions would have liked a break in the payment of dividends.